Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Auto/Allo Transplant with TLI/ATG in Multiple Myeloma
NCT00899847Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2009
- Primary completion
- Apr 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of antithymocyte globulin in multiple myeloma (MM), sponsored by Stanford University. Primary endpoint: Incidence of Graft Versus Host Disease at 2 years. Started May 2009; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00899847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00899847.